055550:KRX

Shinhan Financial Group Co., Ltd.

Data as of 2026-03-10 - not real-time

₩89,200.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Shinhan Financial Group trades around KRW 89,200, well below the analyst median target of KRW 110,000, implying roughly a 24% upside. Forward P/E of 7.1 is dramatically lower than the industry average of 17.4, signaling an undervalued position. The stock offers an attractive dividend yield of 3.98% with a modest payout ratio of 22.9%, suggesting sustainable cash returns. Fundamentals are solid: revenue growth of 21.6% YoY, operating margin of 36.7% and ROE of 8.5% underline strong profitability. Technicals are mixed – the price sits below the 20‑day SMA (96,720) but above the 50‑day and 200‑day SMAs, the RSI is neutral at 44, and a bearish MACD histogram signals short‑term momentum weakness. Nonetheless, the broader market sentiment is extremely bullish (Fear & Greed Index 81) and volume is increasing, supporting a longer‑run buying case.
The low beta of 0.42 indicates limited market‑wide volatility, yet the 30‑day price volatility is high at 50%, flagging short‑term price swings. With a max drawdown of just 16.5% and a strong analyst consensus ("strong buy" from 21 analysts), the risk‑adjusted profile is appealing. The combination of deep valuation discount, robust dividend, and solid earnings growth makes Shinhan a compelling candidate for medium‑ to long‑term investors, while traders should remain cautious of the current bearish MACD and price positioning relative to the short‑term SMA.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD histogram indicating weakening momentum
  • Price below 20‑day SMA suggesting short‑term support pressure
  • High 30‑day volatility (≈50%) increasing near‑term risk

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Forward P/E of 7.1 vs industry 17.4 – strong valuation upside
  • Sustainable dividend yield of 3.98% with low payout ratio
  • Revenue growth of 21.6% and operating margin of 36.7% supporting earnings expansion

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Consistent ROE of 8.5% indicating efficient capital use
  • Low beta (0.42) reducing market‑wide systematic risk
  • Analyst consensus of strong‑buy and target price 24% above current level

Key Metrics & Analysis

Financial Health

Revenue Growth21.60%
Profit Margin31.62%
P/E Ratio7.1
ROE8.53%
ROA0.67%
Op. Cash Flow₩-14362386366464
Industry P/E17.4

Technical Analysis

TrendBullish
RSI44.2
Support₩0.00
Resistance₩107,200.00
MA 20₩96,720.00
MA 50₩87,132.00
MA 200₩73,144.00
MACDBearish
VolumeIncreasing
Fear & Greed Index81.02

Valuation

Target Price₩110,804.77
Upside/Downside24.22%
GradeUndervalued
TypeBlend
Dividend Yield3.98%

Risk Assessment

Beta0.42
Volatility50.46%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.